Search
Monday 31 August 2015
  • :
  • :

Pre-Market Stocks Roundup: Mobil’nye Telesystemy(NYSE:MBT), Pretium Resources (NYSE:PVG), Celldex Therapeutics, (NASDAQ:CLDX), Trinity Industries (NYSE:TRN)

On Thursday, Mobil’nye Telesystemy PAO (ADR) (NYSE:MBT)’s shares declined -1.55% to $7.61.

Mobile TeleSystems PJSC (MBT), the leading telecommunications provider in Russia and the CIS, recently declares its unaudited IFRS financial results for the three months ended June 30, 2015.

Key Financial Highlights of Q2 2015

  • Merged group revenue raised 3.9% y-o-y to RUB 102.7 bln
  • Total revenue in Russia rose 4.4% y-o-y to RUB 94.3 bln
  • Mobile service revenue in Russia improved 2.8% y-o-y to RUB 72.7 bln
  • Data traffic revenue in Russia grew 23.4% y-o-y to RUB 18.9 bln
  • Key Corporate and Industry Highlights
  • Signed a USD 200 mln equivalent term loan facility agreement with China Development Bank Corporation (“CDB”) in renminbi and US dollars
  • Accomplished dividend payment of RUB 19.56 per ordinary MTS share (RUB 39.12 per ADR), or a total of RUB 40.419 bln based on the full-year 2014 financial results
  • Semi-annual dividend recommendation by the MTS Board of RUB 5.61 per ordinary MTS share (RUB 11.22 per ADR), or a total of RUB 11.592 bln based on H1 2015 financial results
  • Signed binding agreements to acquire 100% of the shares of NVision Group JSC, the developer and owner of the MTS billing system and one of the largest system integrators and complex IT solutions providers in Russia, for a total enterprise value up to RUB 15 billion, counting debt

Mobile TeleSystems Public Joint Stock Company provides telecommunication services in Russia and the Commonwealth of Independent States. It offers a range of mobile and fixed line voice and data telecommunications services, counting data transfer, broadband, pay-TV, and various value-added services, in addition to sells equipment and accessories. The company also provides voice and SMS-based value-added services; and Internet access.
Pretium Resources Inc (NYSE:PVG)’s shares gained 0.71% to $5.67.

Pretium Resources Inc. (PVG) report the following highlights from the second quarter of 2015 and updates for its high-grade gold Brucejack Project in northern British Columbia.

Second Quarter 2015 Highlights and NoteworthyEvents

  • On April 2, 2015, we declared that we had reached a comprehensive Cooperation and Benefits Agreement with the Nisga’a Nation in respect of our Brucejack Project (see news release dated April 2, 2015). This Agreement establishes a long-term, mutually-beneficial relationship between Pretivm and the Nisga’a Nation, who have rights and interests as defined by the Nisga’a Final Agreementin the Nass Area where portions of the Project are located.
  • On May 13, 2015, we declared that Robert Quartermain had been designated as Chairman and Chief Executive Officer, Joseph Ovsenek was promoted to President, Michelle Romero was promoted to Vice President, Corporate and Kevin Torpy was promoted to General Manager - Brucejack Mine.
  • On May 20, 2015, we declared a private placement of flow-through common shares of the Company, at a price of $8.75 per share. The private placement was accomplished on June 8, 2015 and a total of 800,000 flow-through shares were issued, for total gross proceeds of about $7,000,000. The proceeds from the private placement will be used to fund grass-roots exploration with an airborne geophysical program and a surface drill program targeting geophysical anomalies east of the Brucejack Project.

Pretium Resources Inc. acquires, explores, and develops precious metal resource properties in the Americas. Its mineral interests comprise of gold/copper/silver exploration projects. The company primarily holds a 100% interest in the Brucejack project, which comprises of about 11 mineral claims covering an area of 3,199.28 hectares located in Northwestern British Colombia. It also holds a 100% interest in the Snowfield project that comprises one mineral claim with an area of about 1,267.43 hectares. Pretium Resources Inc. was incorporated in 2010 and is headquartered in Vancouver, Canada.

At the end of Thursday’s trade, Celldex Therapeutics, Inc. (NASDAQ:CLDX)‘s shares dipped -10.73% to $13.48.

Celldex Therapeutics, Inc. (CLDX) stated business and financial highlights for the second quarter ended June 30, 2015.

Program Updates:

RINTEGA(R) (an EGFRvIII(v3)-specific therapeutic vaccine for glioblastoma (GBM)

  • In June, the independent Data Safety and Monitoring Board (DSMB) recommended continuation of the Phase 3 ACT IV study of RINTEGA(R) (rindopepimut) in patients with newly diagnosed glioblastoma as a result of a prespecified interim analysis assessing safety, futility and efficacy at 50% of events (deaths). The ACT IV study is a randomized, double-blind, placebo controlled study of RINTEGA plus GM-CSF added to standard of care temozolomide in patients with newly diagnosed, surgically resected, EGFRvIII-positive glioblastoma. 745 patients were enrolled into ACT IV to reach the required 374 patients with minimal residual disease (assessed by central review) needed for analysis of the primary overall survival endpoint. All patients, counting those with disease that exceed this threshold, will be comprised of in a secondary analysis of overall survival in addition to analyses of progression-free survival, safety and tolerability, and quality of life. The second interim analysis is predictable to occur in late 2015/early 2016.

Celldex Therapeutics, Inc., a biopharmaceutical company, develops, manufactures, and commercializes novel therapeutics for human health care in the United States. The company’s lead drug candidates comprise rindopepimut (CDX-110), a targeted immunotherapeutic in a pivotal Phase III study for the treatment of front-line glioblastoma, in addition to in Phase II study for the treatment of recurrent glioblastoma; and Glembatumumab vedotin (CDX-011), a targeted antibody-drug conjugate in a randomized Phase IIb study for the treatment of triple negative breast cancer, in addition to in Phase II study for the treatment of metastatic melanoma.

Trinity Industries Inc (NYSE:TRN)), ended its Thursday’s trading session with 25.92% loss, and closed at $25.92.

Trinity Industries, Inc. (TRN) declared earnings results for the second quarter ended June 30, 2015, counting the following noteworthy highlights:

  • Second quarter earnings per common diluted share of $1.33 contrast to $1.01 for the second quarter of 2014, a 32% enhance year-over-year.
  • Quarterly revenue and net income of $1.68 billion and $212.0 million, respectively, a year-over-year enhance of 13% and 29%, respectively.
  • Rail and Inland Barge Groups stated record operating profit during the second quarter.
  • Rail Group delivered 8,530 railcars and received orders for 11,170 new railcars during the second quarter, increasing its backlog to $6.90 billion.
  • Structural wind towers business received orders totaling $183.9 million, increasing its backlog to $502.6 million.
  • Company raised earnings guidance for full year 2015 to between $4.45 and $4.75 per common diluted share contrast to previous guidance of between $4.10 and $4.45 per share.

Business Group Results

In the second quarter of 2015, the Rail Group stated revenues and record operating profit of about $1.11 billion and $227.7 million, respectively, resulting in year-over-year enhances contrast to the second quarter of 2014 of 24% and 29%, respectively. The enhances in revenues and profit were due primarily to higher deliveries, improved pricing, and raised operating efficiencies partially offset by product mix changes. The Rail Group shipped 8,530 railcars and received orders for 11,170 railcars during the second quarter. The Rail Group had a backlog of $6.90 billion as of June 30, 2015, representing 59,830 railcars, contrast to a backlog of $6.81 billion as of March 31, 2015, representing 57,190 railcars.

Trinity Industries, Inc. provides various products and services for the energy, transportation, chemical, and construction sectors in the United States and internationally. Its Rail Group segment offers railcars, counting autorack, box, covered hopper, gondola, intermodal, tank, and open hopper cars; and couplers, axles, and other equipment, in addition to railcar maintenance services. This segment serves railroads, leasing companies, and industrial shippers of various products.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.




Leave a Reply

Your email address will not be published. Required fields are marked *